232 related articles for article (PubMed ID: 34581850)
1. Clinicopathological and prognostic significance of immunophenotypic characterization of endocervical adenocarcinoma using CLDN18, CDH17, and PAX8 in association with HPV status.
Asaka S; Nakajima T; Ida K; Asaka R; Kobayashi C; Ito M; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2022 Feb; 480(2):269-280. PubMed ID: 34581850
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotype analysis using CLDN18, CDH17, and PAX8 for the subcategorization of endocervical adenocarcinomas in situ: gastric-type, intestinal-type, gastrointestinal-type, and Müllerian-type.
Asaka S; Nakajima T; Kugo K; Kashiwagi R; Yazaki N; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2020 Apr; 476(4):499-510. PubMed ID: 31932920
[TBL] [Abstract][Full Text] [Related]
3. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract][Full Text] [Related]
4. [Endocervical adenocarcinomas classified by International Endocervical Adenocarcinoma Criteria and Classification: a clinicopathological and prognostic analysis of 286 cases].
Lyu BJ; Shi HY; Shao Y; Liu Q; Lyu WG
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1014-1019. PubMed ID: 34496491
[No Abstract] [Full Text] [Related]
5. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.
Wada T; Ohishi Y; Kaku T; Aman M; Imamura H; Yasutake N; Sonoda K; Kato K; Oda Y
Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
[TBL] [Abstract][Full Text] [Related]
7. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Asaka S; Nakajima T; Momose M; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2019 Jan; 474(1):79-86. PubMed ID: 30324235
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'.
Mikami Y; Kiyokawa T; Hata S; Fujiwara K; Moriya T; Sasano H; Manabe T; Akahira J; Ito K; Tase T; Yaegashi N; Sato I; Tateno H; Naganuma H
Mod Pathol; 2004 Aug; 17(8):962-72. PubMed ID: 15143335
[TBL] [Abstract][Full Text] [Related]
9. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
[TBL] [Abstract][Full Text] [Related]
10. Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020).
Shi H; Shao Y; Zhang H; Ye L; Xu E; Lu B
Pathology; 2022 Aug; 54(5):555-562. PubMed ID: 35346505
[TBL] [Abstract][Full Text] [Related]
11. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in invasive adenocarcinoma of the cervix.
Stolnicu S; Hoang L; Soslow RA
Virchows Arch; 2019 Nov; 475(5):537-549. PubMed ID: 31209635
[TBL] [Abstract][Full Text] [Related]
13. The Evolving Spectrum of Precursor Lesions of Cervical Adenocarcinomas.
Stolnicu S; Talia KL; McCluggage WG
Adv Anat Pathol; 2020 Sep; 27(5):278-293. PubMed ID: 32482967
[TBL] [Abstract][Full Text] [Related]
14. The developing spectrum of gastric-type cervical glandular lesions.
Talia KL; McCluggage WG
Pathology; 2018 Feb; 50(2):122-133. PubMed ID: 29233547
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and genetic characteristics of HPV-associated endocervical carcinoma with an invasive stratified mucin-producing carcinoma (ISMC) component.
Park E; Kim YT; Kim S; Nam EJ; Cho NH
Mod Pathol; 2021 Sep; 34(9):1738-1749. PubMed ID: 34103667
[TBL] [Abstract][Full Text] [Related]
16. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
Park KJ
Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.
Ito R; Oue N; Yoshida K; Kunimitsu K; Nakayama H; Nakachi K; Yasui W
Virchows Arch; 2005 Oct; 447(4):717-22. PubMed ID: 16044349
[TBL] [Abstract][Full Text] [Related]
19. Coupling CDH17 and CLDN18 markers for comprehensive membrane-targeted detection of human gastric cancer.
Matsusaka K; Ushiku T; Urabe M; Fukuyo M; Abe H; Ishikawa S; Seto Y; Aburatani H; Hamakubo T; Kaneda A; Fukayama M
Oncotarget; 2016 Sep; 7(39):64168-64181. PubMed ID: 27580354
[TBL] [Abstract][Full Text] [Related]
20. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
Stolnicu S; Boros M; Hoang L; Almadani N; de Brot L; Baiocchi G; Bonvolim G; Parra-Herran C; Lerias S; Felix A; Roma A; Pesci A; Oliva E; Park K; Soslow RA; Abu-Rustum NR
Int J Gynecol Cancer; 2021 Feb; 31(2):177-184. PubMed ID: 33177150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]